{"id":116995,"date":"2026-06-15T12:12:06","date_gmt":"2026-06-15T06:42:06","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=116995"},"modified":"2026-06-15T12:12:09","modified_gmt":"2026-06-15T06:42:09","slug":"indegene-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/","title":{"rendered":"Indegene Share Price Target 2026 Analyst Forecast Bull and Bear Case"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>The Indegene share price target 2026 is Rs 610, implying approximately 20 percent upside from the current market price of Rs 510.35 (NSE: INDGN). With Q4 FY26 results released in 2026 and Healthcare Technology and Life Sciences Services sector tailwinds accelerating, the path to Rs 610 is supported by FY27 earnings recovery.<\/em><\/p>\n<p>The <strong><a href=\"https:\/\/univest.in\/user\/stocks\/indgn\/indegene-ltd-share-price-today\">Indegene<\/a> share price target 2026<\/strong> is Rs 610, based on analyst estimates and the FY27 earnings recovery thesis for Indegene (NSE: INDGN). Q4 FY26 results released in 2026 are the immediate re-rating trigger. This article covers the complete <strong>Indegene share price target<\/strong> analysis including sector tailwinds, peer context, key risks, and bull and bear case scenarios.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#Indegene_Share_Price_Target_2026_Key_Takeaways\" title=\"Indegene Share Price Target 2026: Key Takeaways\">Indegene Share Price Target 2026: Key Takeaways<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#Indegene_Company_Overview\" title=\"Indegene Company Overview\">Indegene Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#Why_Is_the_Indegene_Share_Price_Target_Set_at_Rs_610_for_2026\" title=\"Why Is the Indegene Share Price Target Set at Rs 610 for 2026\">Why Is the Indegene Share Price Target Set at Rs 610 for 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#FY27_Earnings_Delivery_and_Revenue_Acceleration\" title=\"FY27 Earnings Delivery and Revenue Acceleration\">FY27 Earnings Delivery and Revenue Acceleration<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#Structural_Sector_Tailwinds_in_Healthcare_Technology_and_Life_Sciences_Services\" title=\"Structural Sector Tailwinds in Healthcare Technology and Life Sciences Services\">Structural Sector Tailwinds in Healthcare Technology and Life Sciences Services<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\" title=\"RBI Rate Cut Cycle and Lower Cost of Capital\">RBI Rate Cut Cycle and Lower Cost of Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#Union_Budget_2026-27_Policy_Support\" title=\"Union Budget 2026-27 Policy Support\">Union Budget 2026-27 Policy Support<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#Improving_FII_Flows_and_Market_Normalisation_in_2026\" title=\"Improving FII Flows and Market Normalisation in 2026\">Improving FII Flows and Market Normalisation in 2026<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#Indegene_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\" title=\"Indegene Share Price Targets: Short Term, 12 Month, and Long Term\">Indegene Share Price Targets: Short Term, 12 Month, and Long Term<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#Short_Term_Indegene_Share_Price_Target\" title=\"Short Term Indegene Share Price Target\">Short Term Indegene Share Price Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#12-Month_Indegene_Share_Price_Target_2026\" title=\"12-Month Indegene Share Price Target 2026\">12-Month Indegene Share Price Target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#Long_Term_Indegene_Share_Price_Target_FY27_to_FY28\" title=\"Long Term Indegene Share Price Target: FY27 to FY28\">Long Term Indegene Share Price Target: FY27 to FY28<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#Bull_Case_and_Bear_Case_for_the_Indegene_Share_Price_Target\" title=\"Bull Case and Bear Case for the Indegene Share Price Target\">Bull Case and Bear Case for the Indegene Share Price Target<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#Bull_Case_Indegene_Share_Price_Target_Rs_740\" title=\"Bull Case Indegene Share Price Target: Rs 740\">Bull Case Indegene Share Price Target: Rs 740<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#Bear_Case_Indegene_Share_Price_Target_Rs_410\" title=\"Bear Case Indegene Share Price Target: Rs 410\">Bear Case Indegene Share Price Target: Rs 410<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#Key_Risks_to_the_Indegene_Share_Price_Target_2026\" title=\"Key Risks to the Indegene Share Price Target 2026\">Key Risks to the Indegene Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#Global_Macro_and_Tariff_Risk\" title=\"Global Macro and Tariff Risk\">Global Macro and Tariff Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#Valuation_and_Earnings_Miss_Risk\" title=\"Valuation and Earnings Miss Risk\">Valuation and Earnings Miss Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#Competitive_Pressure_in_Healthcare_Technology_and_Life_Sciences_Services\" title=\"Competitive Pressure in Healthcare Technology and Life Sciences Services\">Competitive Pressure in Healthcare Technology and Life Sciences Services<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#FII_Selling_and_Liquidity_Risk\" title=\"FII Selling and Liquidity Risk\">FII Selling and Liquidity Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#How_to_Invest_in_Indegene\" title=\"How to Invest in Indegene\">How to Invest in Indegene<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#FAQs_on_Indegene_Share_Price_Target_2026\" title=\"FAQs on Indegene Share Price Target 2026\">FAQs on Indegene Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#What_is_the_Indegene_share_price_target_for_2026\" title=\"What is the Indegene share price target for 2026?\">What is the Indegene share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#What_is_the_Indegene_share_price_target_for_2025\" title=\"What is the Indegene share price target for 2025?\">What is the Indegene share price target for 2025?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#Is_Indegene_a_good_buy_at_Rs_51035\" title=\"Is Indegene a good buy at Rs 510.35?\">Is Indegene a good buy at Rs 510.35?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#What_is_the_52_week_high_and_low_of_Indegene\" title=\"What is the 52 week high and low of Indegene?\">What is the 52 week high and low of Indegene?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#What_are_the_key_risks_to_the_Indegene_share_price_target\" title=\"What are the key risks to the Indegene share price target?\">What are the key risks to the Indegene share price target?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#What_are_the_catalysts_for_the_Indegene_share_price_target\" title=\"What are the catalysts for the Indegene share price target?\">What are the catalysts for the Indegene share price target?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#How_does_Indegene_compare_to_its_peers\" title=\"How does Indegene compare to its peers?\">How does Indegene compare to its peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/indegene-share-price-target-2026\/#What_is_the_Indegene_share_price_target_for_2027\" title=\"What is the Indegene share price target for 2027?\">What is the Indegene share price target for 2027?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Indegene_Share_Price_Target_2026_Key_Takeaways\"><\/span><strong>Indegene Share Price Target 2026: Key Takeaways<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Indegene share price target 2026:<\/strong> Rs 610 (20% upside from CMP Rs 510.35)<\/li>\n<li><strong>Bull case:<\/strong> Rs 740 | <strong>Bear case:<\/strong> Rs 410<\/li>\n<li><strong>Ticker:<\/strong> INDGN | <strong>Sector:<\/strong> Healthcare Technology and Life Sciences Services | <strong>MCap:<\/strong> Rs 12,756 crore<\/li>\n<li><strong>52W range:<\/strong> Rs 420 to Rs 800 | <strong>PE:<\/strong> 45x<\/li>\n<li><strong>Key catalyst:<\/strong> Q4 FY26 results released in 2026 confirming FY27 earnings trajectory<\/li>\n<li><strong>Key risk:<\/strong> FY27 earnings miss or sustained FII outflows from Indian equities<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Indegene_Company_Overview\"><\/span><strong>Indegene Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Indegene (NSE: INDGN) is a Bengaluru-based healthcare technology company providing digital and data-driven services to global life sciences, pharmaceutical, and medical device companies, listed in 2024, with FY26 revenue growing 25 percent year-on-year from expanding US pharma commercialisation mandates. At CMP Rs 510.35 against a 52 week range of Rs 420 to Rs 800, the stock trades at a discount to its 52 week high. Market capitalisation is Rs 12,756 crore with trailing PE of 45x. Compared to peers in healthcare IT like Syneos Health and IQVIA, Indegene is positioned as a potential re-rating candidate toward the <strong>Indegene share price target<\/strong> of Rs 610.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>INDGN<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Healthcare Technology and Life Sciences Services<\/td>\n<\/tr>\n<tr>\n<td>CMP (2026)<\/td>\n<td>Rs 510.35<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 800<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 420<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 12,756 crore<\/td>\n<\/tr>\n<tr>\n<td>Trailing PE<\/td>\n<td>45x<\/td>\n<\/tr>\n<tr>\n<td>12-Month Analyst Target<\/td>\n<td>Rs 610<\/td>\n<\/tr>\n<tr>\n<td>Bull Case Target<\/td>\n<td>Rs 740<\/td>\n<\/tr>\n<tr>\n<td>Bear Case Target<\/td>\n<td>Rs 410<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div style=\"background: #E8EAFF; border-radius: 14px; padding: 28px 32px 24px 32px; margin: 24px 0; font-family: -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,sans-serif; cursor: pointer; max-width: 100%; box-sizing: border-box;\">\n<p style=\"font-size: 20px; font-weight: bold; color: #0a0a23; margin: 0 0 12px 0; line-height: 1.3;\">3 Stocks Building Serious Momentum Right Now<\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">When <strong style=\"color: #0a0a23;\">Univest analysts<\/strong> identify high-conviction stock opportunities, <em>investors pay attention.<\/em><\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">Our research team has now shortlisted the <strong style=\"color: #0a0a23;\">Top Stocks to Buy<\/strong> based on current market momentum, sector trends &amp; growth potential for 2026.<\/p>\n<ul style=\"margin: 0 0 16px 20px; padding: 0; color: #3a3a5c; font-size: 15px; line-height: 1.8;\">\n<li>Discover stocks investors are actively accumulating<\/li>\n<li>High-conviction opportunities backed by research<\/li>\n<li>Designed for the next phase of market growth<\/li>\n<\/ul>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 20px 0;\">Unlock the latest <a style=\"color: #3b7fff; font-weight: bold; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">Top Stock Picks<\/a> now on Univest<\/p>\n<p><a style=\"display: inline-block; background: #3B7FFF; color: #fff; font-size: 15px; font-weight: 600; padding: 13px 28px; border-radius: 50px; letter-spacing: 0.2px; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">See the Stocks \u2192<\/a><\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Why_Is_the_Indegene_Share_Price_Target_Set_at_Rs_610_for_2026\"><\/span><strong>Why Is the Indegene Share Price Target Set at Rs 610 for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Delivery_and_Revenue_Acceleration\"><\/span><strong>FY27 Earnings Delivery and Revenue Acceleration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>Indegene share price target 2026<\/strong> of Rs 610 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings recovery trajectory are the most direct catalyst for re-rating from CMP Rs 510.35 toward Rs 610.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Structural_Sector_Tailwinds_in_Healthcare_Technology_and_Life_Sciences_Services\"><\/span><strong>Structural Sector Tailwinds in Healthcare Technology and Life Sciences Services<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Healthcare Technology and Life Sciences Services sector is expanding on the back of India&#8217;s domestic demand growth, PLI scheme support, and rising investment. Indegene&#8217;s market position among peers in healthcare IT like Syneos Health and IQVIA creates a structural growth runway supporting the <strong>Indegene share price target<\/strong> of Rs 610 and bull case of Rs 740.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\"><\/span><strong>RBI Rate Cut Cycle and Lower Cost of Capital<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s RBI rate cut cycle in 2026 reduces Indegene&#8217;s borrowing costs and stimulates end market demand. Lower interest costs improve the EPS trajectory, directly supporting the <strong>Indegene share price target<\/strong> of Rs 610.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Union_Budget_2026-27_Policy_Support\"><\/span><strong>Union Budget 2026-27 Policy Support<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Budget 2026-27&#8217;s Rs 11.21 lakh crore infrastructure capex and PLI scheme continuity create a positive policy backdrop for Indegene&#8217;s Healthcare Technology and Life Sciences Services operations, improving the probability of achieving the <strong>Indegene share price target<\/strong> of Rs 610.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Improving_FII_Flows_and_Market_Normalisation_in_2026\"><\/span><strong>Improving FII Flows and Market Normalisation in 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As global macro conditions normalise through 2026, FII flows into quality Indian equities are recovering. At 45x PE, Indegene is positioned as a beneficiary of institutional reallocation toward the <strong>Indegene share price target<\/strong> of Rs 610.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Indegene_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\"><\/span><strong>Indegene Share Price Targets: Short Term, 12 Month, and Long Term<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Short_Term_Indegene_Share_Price_Target\"><\/span><strong>Short Term Indegene Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The near-term <strong>Indegene share price target<\/strong> is anchored to support near the 52 week low of Rs 420. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating toward Rs 610.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"12-Month_Indegene_Share_Price_Target_2026\"><\/span><strong>12-Month Indegene Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 12-month <strong>Indegene share price target 2026<\/strong> is Rs 610, implying approximately 20 percent upside from CMP Rs 510.35. This base case assumes in-line FY27 earnings delivery and partial FII flow normalisation. Track live on NSE ticker INDGN.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Long_Term_Indegene_Share_Price_Target_FY27_to_FY28\"><\/span><strong>Long Term Indegene Share Price Target: FY27 to FY28<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>For investors with a 2 to 3 year horizon, the long-term <strong>Indegene share price target<\/strong> is Rs 740 in the bull case, assuming full earnings delivery and sector re-rating among peers in healthcare IT like Syneos Health and IQVIA.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_and_Bear_Case_for_the_Indegene_Share_Price_Target\"><\/span><strong>Bull Case and Bear Case for the Indegene Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Bull_Case_Indegene_Share_Price_Target_Rs_740\"><\/span><strong>Bull Case Indegene Share Price Target: Rs 740<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The bull case of Rs 740 materialises when FY27 earnings beat analyst estimates, Healthcare Technology and Life Sciences Services tailwinds accelerate, and FII flows return strongly, enabling re-rating toward higher peer multiples in 2026 and beyond.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bear_Case_Indegene_Share_Price_Target_Rs_410\"><\/span><strong>Bear Case Indegene Share Price Target: Rs 410<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The bear case of Rs 410 materialises if FY27 earnings disappoint and FII outflows persist, with the stock approaching the 52 week low support of Rs 420.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Target<\/th>\n<th>Key Conditions<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 740<\/td>\n<td>FY27 earnings beat, re-rating, FII inflows<\/td>\n<\/tr>\n<tr>\n<td>Base Case<\/td>\n<td>Rs 610<\/td>\n<td>In-line FY27 delivery, partial FII recovery<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 410<\/td>\n<td>FY27 miss, guidance cut, FII outflows<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_the_Indegene_Share_Price_Target_2026\"><\/span><strong>Key Risks to the Indegene Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Global_Macro_and_Tariff_Risk\"><\/span><strong>Global Macro and Tariff Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Global tariff tensions and macro headwinds remain a key risk to the <strong>Indegene share price target 2026<\/strong> of Rs 610, with FII outflows a direct consequence of sustained geopolitical uncertainty.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_and_Earnings_Miss_Risk\"><\/span><strong>Valuation and Earnings Miss Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Any FY27 earnings miss or guidance cut could compress multiples, posing the most direct risk to the <strong>Indegene share price target<\/strong> of Rs 610.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Competitive_Pressure_in_Healthcare_Technology_and_Life_Sciences_Services\"><\/span><strong>Competitive Pressure in Healthcare Technology and Life Sciences Services<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Intensifying competition among peers in healthcare IT like Syneos Health and IQVIA could compress Indegene&#8217;s pricing power, a structural risk that must be factored into any assessment of the <strong>Indegene share price target<\/strong> of Rs 610.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FII_Selling_and_Liquidity_Risk\"><\/span><strong>FII Selling and Liquidity Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sustained FII outflows from Indian equities can delay re-rating toward the <strong>Indegene share price target<\/strong> of Rs 610 regardless of company-level improvement through FY27.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Indegene\"><\/span><strong>How to Invest in Indegene<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data<\/strong><\/a><\/p>\n<p>Begin by reviewing Indegene&#8217;s Q4 FY26 results, annual report, and FY27 guidance released in 2026 before forming a view on the <strong>Indegene share price target<\/strong> of Rs 610. Focus on revenue growth, margin trends, and management commentary on Healthcare Technology and Life Sciences Services sector opportunities.<\/p>\n<p>Open a Demat and trading account with a SEBI registered stockbroker to buy Indegene (NSE: INDGN) with full regulatory protection. Understand the competitive dynamics among peers in healthcare IT like Syneos Health and IQVIA before executing any position.<\/p>\n<p>Plan your entry near the 52 week low support of Rs 420. A confirmed FY27 earnings uptick would strengthen the entry case for the <strong>Indegene share price target<\/strong> of Rs 610. Set a disciplined stop loss below the 52 week low.<\/p>\n<p>Restrict any single stock to 3 to 5 percent of your total equity portfolio to manage concentration risk, especially in the Healthcare Technology and Life Sciences Services space where sectoral cycles can amplify volatility.<\/p>\n<p>Always consult a SEBI registered financial advisor before investing based on any <strong>Indegene share price target<\/strong> estimate. SEBI Registration No. INH000013776.<\/p>\n<p><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Indegene&#8217;s live price and get daily stock recommendations.<\/em><\/p>\n<div style=\"background: #C0392B; padding: 20px 24px; border-radius: 4px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 15px; font-weight: bold; margin: 0; line-height: 1.7;\"><strong>Disclaimer Note:<\/strong> The securities quoted, if any, are for illustration only and are not recommendatory. This content is for educational purposes only and does not constitute investment advice. Investments in securities are subject to market risk. Read all related documents carefully before investing. SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Indegene_Share_Price_Target_2026\"><\/span><strong>FAQs on Indegene Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Indegene_share_price_target_for_2026\"><\/span><strong>What is the Indegene share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Indegene share price target 2026 is Rs 610, implying approximately 20 percent upside from CMP Rs 510.35. Bull case is Rs 740 and bear case is Rs 410.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Indegene_share_price_target_for_2025\"><\/span><strong>What is the Indegene share price target for 2025?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Indegene share price target for 2025 was based on FY26 earnings projections. The current 2026 analyst target is Rs 610, reflecting FY27 growth potential from CMP Rs 510.35.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Indegene_a_good_buy_at_Rs_51035\"><\/span><strong>Is Indegene a good buy at Rs 510.35?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> At Rs 510.35, Indegene offers potential upside to the share price target of Rs 610 if FY27 earnings recover as projected. Consult a SEBI registered financial advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52_week_high_and_low_of_Indegene\"><\/span><strong>What is the 52 week high and low of Indegene?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 52 week high of Indegene is Rs 800 and the 52 week low is Rs 420. At CMP Rs 510.35, the stock offers upside potential toward the 12-month share price target of Rs 610.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Indegene_share_price_target\"><\/span><strong>What are the key risks to the Indegene share price target?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks include FY27 earnings miss, US tariff-driven FII outflows, competitive pressure among peers in healthcare IT like Syneos Health and IQVIA, and broader market volatility impacting Indian equities in 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_catalysts_for_the_Indegene_share_price_target\"><\/span><strong>What are the catalysts for the Indegene share price target?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Primary catalysts include FY27 PAT recovery, Healthcare Technology and Life Sciences Services sector tailwinds, RBI rate cut support in 2026, Union Budget 2026-27 policy uplift, and normalisation of FII flows into Indian equities.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Indegene_compare_to_its_peers\"><\/span><strong>How does Indegene compare to its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Indegene operates in Healthcare Technology and Life Sciences Services alongside peers in healthcare IT like Syneos Health and IQVIA. At CMP Rs 510.35 with MCap Rs 12,756 crore, the company is a potential re-rating candidate toward the share price target of Rs 610 on FY27 earnings delivery.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Indegene_share_price_target_for_2027\"><\/span><strong>What is the Indegene share price target for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The long-term Indegene share price target for FY27 to FY28 is Rs 740 in the bull case, assuming continued earnings growth, sector re-rating, and sustained FII inflows. Consult a SEBI registered financial advisor for personalised guidance.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Indegene share price target 2026 is Rs 610, ~20% upside from CMP Rs 510.35. Bull Rs 740, bear Rs 410. 2026.<\/p>\n","protected":false},"author":28,"featured_media":117676,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3972],"class_list":["post-116995","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-share-price-target"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1781505732:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["82"],"rank_math_title":["Indegene Share Price Target 2026: Rs 610 Analyst Forecast"],"rank_math_description":["The Indegene share price target 2026 is Rs 610, ~20% upside from CMP Rs 510.35. Bull Rs 740, bear Rs 410. 2026."],"rank_math_focus_keyword":["Indegene Share Price Target"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_thumbnail_id":["117676"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["17881"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Indegene-Share-Price-Target.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/116995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=116995"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/116995\/revisions"}],"predecessor-version":[{"id":117678,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/116995\/revisions\/117678"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/117676"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=116995"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=116995"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=116995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}